|
1] ALDERBORN, G. (2002) Tablet and compaction. In: Aulton E. Pharmaceutics: the science of dosage form design, 2nd Ed, Churchill Livingstone Lippincott Williams and Wilkins, Longman group, Edinburgh, pp.114-138.
2] BRITISH PHARMACOPOEIA, The department of health, social services and public safety, Great Britain(2005), 5th ed., pp. 1460-1462
3]BOLTON, S. et al. (2004) Pharmaceutical Statistics, practical and clinical applications, Drug and the pharmaceutical sciences. 4th ed., New York: Marcel Dekker, 135, pp. 265-283
4]COOPER, J. et al. Powder flow and compaction, In: Carter S.J., Tutorial Pharmacy, CBS Publishers and distributors, New Delhi, India(1986), pp. 223-233.
5Garg R. and Gupta G. D. Progress in controlled gastroretentive delivery systems. Tropical Journal of Pharmaceutical Research . (2008) : 7: 1055•1056.
6] IMRAN, A. et al., (2012) Development and validation of reversed-phase HPLC method for estimation of Ondansetron hydrochloride in bulk drug. International Research Journal of Pharmacy, 3(2), pp. 111–113.
7] KALAICHELVI, R. et al., UV spectrophotometric method for determination ofsssOndansetron hydrochloride in pure and its formulation. International Journal of Pharmacy and Pharmaceutical Sciences, (2012) 4, pp. 2–3.
8] KHANDELWAL, K. R.Practicalpharmacognosy, Techniques and experiments. NiraliPrakasham, (2009) pp. 42.
9] MUSHABBAR BASHA, M. D. et al., Method development and validation of ondansetron in bulk and pharmaceutical dosage form by stability-indicating RP-HPLC method. International Journal of PharmTech Research, (2013) 5(1), pp. 86-98 Journal of Pharmacy, (2012) ,3(2), pp. 111–113
10] PAL, D. & NAYAK, A. Novel tamarind seed polysaccharide-alginate mucoadhesive microsphere for oral gliclazide delivery?: in vitro–in vivo evaluation. Drug Delivery, (January) (2012), pp. 1-9
|